Standout Papers

Efficacy and Safety of Alirocu... 1992 2026 2003 2014 1.6k
  1. Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events (2015)
    Jennifer G. Robinson, Michel Farnier et al. New England Journal of Medicine
  2. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction (1992)
    François Cambien, Odette Poirier et al. Nature

Immediate Impact

5 by Nobel laureates 12 from Science/Nature 53 standout
Sub-graph 1 of 19

Citing Papers

Global Effect of Modifiable Risk Factors on Cardiovascular Disease and Mortality
2023 Standout
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
2020 StandoutNature

Works of Gérald Luc being referenced

Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events
2015 Standout

Author Peers

Author Last Decade Papers Cites
Gérald Luc 2544 3067 2947 87 8.9k
Alun Evans 2118 1644 3119 107 9.2k
Odette Poirier 3397 1627 4376 115 9.1k
Joseph P. McConnell 1405 2908 2002 109 7.7k
J.J. Emeis 1688 1491 1544 112 7.3k
H. Schulte 3155 3169 2569 126 7.9k
Göran Walldius 2999 2994 1993 184 9.0k
Ron C. Hoogeveen 2577 2962 4094 250 11.1k
Mary J. Malloy 1875 2528 1640 133 7.0k
Aruna D. Pradhan 2830 2425 2359 85 9.6k
Maurizio Averna 2787 5132 2752 284 9.3k

All Works

Loading papers...

Rankless by CCL
2026